Print this page    •   Back to Web version of article

Syringe Exchange and Risk of Infection With Hepatitis B and C Viruses
Abstracted from the American Journal of Epidemiology Online, Vol. 149, No. 3

February 4, 1999

Abstract:

Research conducted as part of the Risk Activity Variables, Epidemiology, and Network Study of intravenous drug users involved in a Seattle-King County, Wash., needle-exchange program indicates that the program was not effective in reducing hepatitis B virus (HBV) or hepatitis C virus (HCV) among the users. The authors of the study note that, while uncontrolled confounding or other bias may have obscured a beneficial impact, the study of 187 HCV-seronegative and 460 HBV-seronegative IDUs did not suggest such an effect. The participants were enrolled in the study between June 1994 and January 1996 and followed for seroconversion one year later. At follow up, there were 39 HCV infections and 46 HBV infections, the researchers report.



This article was provided by U.S. Centers for Disease Control and Prevention. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art17051.html

General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.